Evidence map›Paper›PMID 40911681›Full record

ArticleScience advances2025

Robotic micromanipulation for patterned and complex organoid biofabrication.

Mingsi Tong, Gang Huang, Songlin Zhuang, Xinghu Yu, Delin Hu, Weiyang Lin, Yang Wu, Yuchen Chen, Shijia Cheng, Meng Jiang and 2 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Materiobiology in the omics era.Materials today. Bio · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mingsi TongResearch Institute of Intelligent Control and Systems, Harbin Institute of Technology, Harbin, China.ORCID 0000-0002-1939-0040
Gang HuangResearch Institute of Intelligent Control and Systems, Harbin Institute of Technology, Harbin, China.ORCID 0009-0004-7284-7953
Songlin ZhuangYongjiang Laboratory, Ningbo, China.ORCID 0000-0003-3072-0634
Xinghu YuYongjiang Laboratory, Ningbo, China.ORCID 0000-0001-8181-6199
Delin HuDepartment of Mechanical and Automation Engineering, The Chinese University of Hong Kong, Hong Kong, China.
Weiyang LinResearch Institute of Intelligent Control and Systems, Harbin Institute of Technology, Harbin, China.ORCID 0000-0002-0493-1289
Yang WuResearch Institute of Intelligent Control and Systems, Harbin Institute of Technology, Harbin, China.
Yuchen ChenResearch Institute of Intelligent Control and Systems, Harbin Institute of Technology, Harbin, China.
Shijia ChengResearch Institute of Intelligent Control and Systems, Harbin Institute of Technology, Harbin, China.
Meng JiangResearch Institute of Intelligent Control and Systems, Harbin Institute of Technology, Harbin, China.ORCID 0000-0002-5653-0401
Li ZhangDepartment of Mechanical and Automation Engineering, The Chinese University of Hong Kong, Hong Kong, China.ORCID 0000-0003-1152-8962
Huijun GaoResearch Institute of Intelligent Control and Systems, Harbin Institute of Technology, Harbin, China.ORCID 0000-0001-5554-5452

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organoids have emerged as powerful models for recapitulating tissue physiology and pathology in biomedical research. However, the need for consistent and complex manufacturing of organoids remains a challenge. The absence of standardization and quality control of cells dispersed within extracellular matrices impedes the widespread application of organoids. Here, we introduce a micromanipulation platform that effectively constrains cell distribution to enable patterned and complex organoid biofabrication. This system integrates multidimensional cell sense technology to provide real-time feedback, enabling adaptive fluid dynamics control that robustly compensates for seeding-induced nonlinear fluidic perturbations. Through this closed-loop control, the micromanipulation platform effectively restrains the spatial distribution of multiple cell types, promoting consistent self-assembly. Using this platform, we have successfully achieved programmable organoid manufacturing as well as the construction of assembloids composed of multiple cell types that better mimic mature organ microenvironments. This supports advancements in organoid-based biomechanism discovery, drug screening, and other organoid-related investigations.

Indexed as

MicromanipulationOrganoidsRoboticsTissue EngineeringAnimalsHumans

Identifiers

PMID40911681
PMCPMC12412664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.